Scorpius can support adapted or customized cellular assays to fully characterize or evaluate the efficacy and safety of your therapeutic product. Cell-based assays offer a relevant representation of a real-life model that can evaluate a variety of functional and biochemical effects. This enables the tracking of variables such as the number of cells or their behavior, cell proliferation, apoptosis, signal transduction, enzyme activity, reporter gene activity, antibody- (ADCC) and complement-dependent cytotoxicity (CDC), as well as neutralizing antibody (NAb) assays.
Our team has developed and optimized cellular assays using both primary and transformed cell lines and can validate custom cell-based assays following regulatory guidelines and recommendations. Scorpius offers a diverse range of innovative platforms for any type of cell-based work that allows for multiplexing and automation for increased assay throughput and reproducibility. Our scientists will help you choose the method to optimally support your distinct cell-based assay parameters.